Fritextsökning
Artiklar per år
Innehållstyper
-
IVF ökar inte risk för cancer
En ny dansk studie visar att fertilitetsbehandling inte ökar risken för äggstockscancer. Över femtiotusen kvinnor deltog i studien som är den största hittills av sitt slag.
-
Hallå där, Christel Fenge !
...VD i nya bolaget Recipharm Biologics, som nu i eftermiddag har ovanligt många gäster i lokalerna i Södertälje.
-
Helge Sander: "Fler kvinnor behövs"
- Det är något fel när det ena könet i stort sett väljer bort en karriär som forskare, säger Danmarks forskningsminister. Idag håller han rundabordssamtal för att diskutera varför kvinnliga forskare missgynnas. Han välkomnar alla lösningar, utom en.
-
Hundar kan också få ALS
Forskare har identifierat en genmutation som orsakar amytrofisk lateralskleros hos flera hundraser. Samma gen ligger bakom samma sjukdom hos människor.
-
Stamceller kan stoppa svår MS
Forskare vid Uppsala universitet visar att det är möjligt att stoppa sjukdomen multipel skleros. Genom att behandla patienter med blodstamceller har man lyckats stoppa sjukdomsförloppet.
-
Chr. Hansen köper underlivshälsa
Nio studer har bevisat att Urex kan minska risken för underlivsinfektioner hos kvinnor. Nu flyttas det kanadensiska bolagets verksamhet till Köpenhamn.
-
Major changes to the Q-Med board
The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and one is from the University of Uppsala.
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be re-elected at the AGM in May.
-
A smart company takes care of its best
Lundbeck didn't have to look far to find it's new international Director of Marketing. The talent was already in the house.
-
New CEO to Promedvi
Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Biotage is regrouping
The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.
-
Danisco strengthens its IP team
Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.
-
Medicult needs a word of advice
Medicult Board retains advisers, regarding the previous offer from Vitrolife.
-
Metabolic pro heads prefect post
The dean of the Department of Biomedicine at the Sahlgrenska Academy has appointed a new assistant prefect.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
Apoteket gets new vice CEO
The Swedish government company Apoteket has recently appointed a vice CEO.
-
Swedish nanotech crosses the Atlantic
Genovis signs distribution agreement Finnzymes in US.
BREAKING